Attorney General Raoul Reminds Illinois Residents To Be Vigilant When Seeking GLP-1 Drugs For Weight Loss
CHICAGO – As 2025 begins and millions of Americans start working to keep their New Year’s resolutions, Attorney General Kwame Raoul is reminding Illinois residents who are seeking GLP-1 medications – including Ozempic, Wegovy, Mounjaro and Zepbound – to be aware that many sellers advertising these name brand medications are instead offering unapproved versions of these products that may put people’s health at risk. Weight loss continues to be one of the top New Year’s resolutions among Americans, and Raoul is strongly urging people to obtain prescriptions for GLP-1 medications from a trusted health care provider and to fill those prescriptions at an appropriately-licensed pharmacy. Attorney General Raoul is warning consumers about misleading advertising by med spas, wellness centers, online retailers and social media sellers that states or implies they are offering name brand GLP-1 medications or generic versions of name brand medications, when
stLouIST